State attorneys general yesterday announced a $26 billion proposed settlement with Johnson & Johnson and distributors McKesson, Cardinal Health and Amerisource Bergen over the companies’ alleged role in creating and fueling the opioid epidemic. A number of states have signed the agreement, which still must be signed by other state and local governments involved in the litigation. They said most of the settlement would go to opioid treatment and prevention, with each state’s share based on a formula that takes into account factors such as the number of overdose deaths, opioids prescribed and residents with substance use disorder.

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…